Page 2 - ரோட்னி கேலினேோஉ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரோட்னி கேலினேோஉ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரோட்னி கேலினேோஉ Today - Breaking & Trending Today

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Tier 2 Company
Pursuant to a resolution passed by the shareholders of the Company on December 2, 2020, the Company has consolidated its capital on a fifteen (15) old shares for on (1) new share basis, and the name of the Company has been changed from Gold Rush Cariboo Corp. to Allied Copper Corp.
Effective at the opening of business on Friday, April 9, 2021, the common shares of Allied Copper Corp. will commence trading on the TSX Venture Exchange on a consolidated basis, and the common shares of Gold Rush Cariboo Corp. will be delisted.
The Company is classified as an All other metal ore mining issuer (NAICS Number: 212299). ....

United States , Thunder Bay , British Columbia , Lake Mining District , Paul Marjerrison , David Tait , Rodney Gelineau , Robert Brozdowski , Greg Andrews , Robert Carpenter , David Dreisinger , Ira Sudargo , Daniel Macneil , Ciska Asriel , Jeffery Sundar , Kelly Jennings , Jocelyn Bennett , Venture Exchange The , Market Regulator Of The Exchange , Venture Exchange Bulletins , Gravitas Securities Inc , Exchange Corporate Finance Manual , Nevada King Gold Corp , Venture Exchange Bulletin , Venture Exchange , Insider Pro Group Participation ,

EastWest Bioscience Inc.: EastWest Bioscience Announces Shares for Debt Settlement

EastWest Bioscience Inc.: EastWest Bioscience Announces Shares for Debt Settlement
Company or
EastWest )
(TSXV:EAST) announces the issuance of 3,777,567 common shares at a price of CDN $0.05 per common share to certain non-arm s length and arm s length service providers for settlement in respect of expenses incurred on behalf of the Company by consultants and for consulting services (the
Consultants ) provided to the Company. The transactions with the Consultants were in the normal course of business and the consideration provided was agreed to by the Company and the Consultants.
The Company has received TSX Venture Exchange approval on these said transactions and a statutory hold period of four-months and one day is in place on the issuance of these common shares in accordance with applicable securities laws. ....

United States , British Columbia , United Kingdom , Rodney Gelineau , Kostenloser Wertpapierhandel , Eastwest Bioscience Inc , Head Office , Company Website , Sangster Health Centres , Sangster Health Centre , Health Canada , Company Or Eastwest , Venture Exchange , Health Canada Site , Eastwest Bioscience , West Bioscience , Health Centre , Health Centres , Vale Naturals , Health Canada Site License , Chief Executive Officer , Further Information , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , ஒன்றுபட்டது கிஂக்டம் , ரோட்னி கேலினேோஉ ,

EastWest Bioscience Inc.: EastWest Bioscience Posts Triple Digit Growth in Quarterly Manufacturing Revenue; Continues Reduction of G&A Expenses

EastWest Bioscience Inc.: EastWest Bioscience Posts Triple Digit Growth in Quarterly Manufacturing Revenue; Continues Reduction of G&A Expenses
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , United Kingdom , Rodney Gelineau , Kostenloser Wertpapierhandel , Eastwest Bioscience Inc , Head Office , International Financial Reporting Standards , Company Website , Sangster Health Centres , Eastwest Bioscience The Company Or , Sangster Health Centre , Health Canada , Venture Exchange , Health Canada Site , Regulation Services Provider , Eastwest Bioscience , West Highlights , Orchard Vale Naturals , Orchard Vale , West Bioscience , Health Centre , Health Centres , Vale Naturals , Health Canada Site License , Chief Executive Officer ,

EastWest BioScience Inc.: EastWest Bioscience Announces Grant of Options and Debt Settlement

EastWest BioScience Inc.: EastWest Bioscience Announces Grant of Options and Debt Settlement
VANCOUVER, BC / ACCESSWIRE / February 5, 2021 / EastWest Bioscience (the Company or EastWest ) (TSXV:EAST) announces, subject to its stock option plan, the grant of 1,720,000 stock options to certain directors, officers, employees and consultants issued pursuant to the Company s stock option plan. The options vest over a 2 year period, are exercisable at a price of $0.05 per share and expire in February 2024. The shares issuable upon exercise of the options may not be traded for 4 months and one day from the date of grant.
The Company also announces the proposed issuance of approximately 7,000,000 common shares at a price of CDN $0.05 per common share to certain arm s length and non-arm s length individuals and service providers for settlement of a portion owing by the Company in respect of various services rendered, including but not limited to consulting, financial, accounting ....

United States , British Columbia , Rodney Gelineau , Kostenloser Wertpapierhandel , Eastwest Bioscience Inc , Azema Sciences , Company Website , Eastwest Bioscience Group , Eastwest Bioscience The Company Or , Eastwest Health Canada Certified , Venture Exchange , Regulation Services Provider , Eastwest Bioscience , Natural Advancement , Natural Pet Science , Health Canada Licensed , Good Manufacturing Practices , Benchmark Botanicals , Joint Venture Intent , Cannabis Act , Health Canada Certified , Eastwest United States , Joint Venture , West Science United States , West United , Chief Executive Officer ,

Ms. Ciska Asriel: Early Warning Report in Accordance with National Instrument 62-103

Ms. Ciska Asriel: Early Warning Report in Accordance with National Instrument 62-103
Early Warning Requirements of National Instrument 62-103 with respect to EastWest Bioscience Inc. (
EastWest )
Ms. Ciska Asriel, the COO and CFO of EastWest has directly acquired 500,000 common shares by a series of purchases through the facilities of the TSX Venture Exchange at $0.05 per share on February 2, 2021 (the
Shares ).
Prior to giving effect to the foregoing acquisition of securities, Ms. Asriel owned or controlled 9,532,919 Common Shares and 900,000 warrants and options of the Corporation. After giving effect to the acquisition of the Shares, Ms. Asriel owns or controls 10,032,919 Shares (or approximately 10.77% of the issued and outstanding Shares of EastWest (non-diluted)) and 900,000 options and warrants. ....

British Columbia , Rodney Gelineau , Kostenloser Wertpapierhandel , Ciska Asriel , Eastwest Bioscience Inc , Venture Exchange , Early Warning Requirements Of National Instrument , Warning Requirements , National Instrument , Eastwest Bioscience , Common Shares , Chief Executive Officer , பிரிட்டிஷ் கொலம்பியா , ரோட்னி கேலினேோஉ , துணிகர பரிமாற்றம் , ஆரம்ப எச்சரிக்கை தேவைகள் ஆஃப் தேசிய கருவி , எச்சரிக்கை தேவைகள் , தேசிய கருவி , பொதுவானது பங்குகள் , தலைமை நிர்வாகி அதிகாரி ,